If you haven`t bought NVAX during the Covid Pandemic:
Then analyzing the options chain and the chart patterns of NVAX Novavax prior to the earnings report this week, I would consider purchasing the 7.50usd strike price Calls with an expiration date of 2024-1-19, for a premium of approximately $0.87. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
I’m long Nvax. Expecting significant improvement to forward guidance during the earnings call. Stock price has been consolidating nicely for several months. Feels like it’s sitting at major support. Thinking about holding it to at least $50 per share. Historical trend shows 7 moves over $100 and 3 or 4 moves over $150. The vaccine approval is big news. Expecting sales outside of the US to be significant and steady into the future.
yurii678
⋅
any chart updates?
AngelitoTD
⋅
So based on options suppose to go up the price?
AngelitoTD
⋅
@AngelitoTD options expiring 17-11-23 are high both calls and putts in 10 usd price. Somebody can explain a bit more?